Q2 2017 Holdings
Filed 2017-08-14 | 13 holdings | $1.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Akebia Therapeutics Inc.(AKBA) | COM | 00972D105 | $719.0K | 50,000 | 63.8% |
| Ardelyx, Inc.(ARDX) | COM | 039697107 | $191.0K | 37,500 | 16.9% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $87.9K | 1,672,714 | 7.8% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $82.1K | 3,992,517 | 7.3% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $22.4K | 1,484,740 | 2.0% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $12.0K | 1,043,832 | 1.1% |
| NanoString Technologies, Inc.(NSTGEUR) | COM | 63009R109 | $4.2K | 254,015 | 0.4% |
| Dermira, Inc.(DERMEUR) | COM | 24983L104 | $3.9K | 135,294 | 0.3% |
| Orexigen Therapeutics, Inc. | COM | 686164302 | $1.7K | 602,013 | 0.2% |
| Jounce Therapeutics, Inc.(JNCEEUR) | COM | 481116101 | $1.7K | 119,912 | 0.1% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $591 | 50,559 | 0.1% |
| Zafgen, Inc. | COM | 98885E103 | $420 | 119,695 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | COM | 800677106 | $405 | 46,000 | 0.0% |